The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Lieber Jonathan I | Chief Financial Officer | Sell(S) | 789 | $5.06 | $4K |
| Feb 18, 2026 | Mackay Martin | Director | Grant(A) | 18K | $3.60 | $65K |
| Feb 18, 2026 | Hunt Ronald | Director | Grant(A) | 14K | $3.60 | $51K |
| Feb 18, 2026 | Lieber Jonathan I | Chief Financial Officer | Grant(A) | 3K | — | $0 |
| May 13, 2025 | Mackay Martin | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Liu Hui | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Soteropoulos Paula | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Hopfner Robert Lorne | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Nash Christine A | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Hunt Ronald | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Chung Wendy | Director | Grant(A) | 29K | — | $0 |
| May 13, 2025 | Boudreau Helen M | Director | Grant(A) | 29K | — | $0 |
| Feb 14, 2025 | Lieber Jonathan I | Chief Financial Officer | Grant(A) | 180K | — | $0 |
| Feb 14, 2025 | Ryder Steven | Chief Medical Officer | Grant(A) | 180K | — | $0 |
| Feb 14, 2025 | Uden Stephen | Chief Executive Officer, Director | Grant(A) | 454K | — | $0 |
| Jan 2, 2025 | Liu Hui | Director | Grant(A) | 68K | $0.70 | $47K |
| Jan 2, 2025 | Hopfner Robert Lorne | Director | Grant(A) | 74K | $0.70 | $51K |
| Jan 2, 2025 | Hunt Ronald | Director | Grant(A) | 74K | $0.70 | $51K |
| Jan 2, 2025 | Mackay Martin | Director | Grant(A) | 93K | $0.70 | $65K |
| May 15, 2024 | Chung Wendy | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Hopfner Robert Lorne | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Nash Christine A | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Soteropoulos Paula | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Parmar Kush | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Liu Hui | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Boudreau Helen M | Director | Grant(A) | 17K | — | $0 |
| May 15, 2024 | Hunt Ronald | Director | Grant(A) | 17K | — | $0 |
| Feb 15, 2024 | Uden Stephen | Chief Executive Officer, Director | Grant(A) | 216K | — | $0 |
| Feb 15, 2024 | Mackay Martin | Executive Chairman, Director | Grant(A) | 216K | — | $0 |
| Feb 15, 2024 | Lieber Jonathan I | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Feb 15, 2024 | Ryder Steven | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Jan 2, 2024 | Parmar Kush | Director | Grant(A) | 27K | $1.77 | $48K |
| Jan 2, 2024 | Hunt Ronald | Director | Grant(A) | 29K | $1.77 | $51K |
| May 17, 2023 | Parmar Kush | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Nash Christine A | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Boudreau Helen M | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Hopfner Robert Lorne | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Soteropoulos Paula | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Liu Hui | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Hunt Ronald | Director | Grant(A) | 15K | — | $0 |
| May 17, 2023 | Chung Wendy | Director | Grant(A) | 12K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).